Illumina develops next-generation tools for the large-scale analysis of genetic variation and function, the results of which will pave the way for personalized medicine, a key goal of genomics and proteomics.
Illumina is a global leader in genomics – an industry at the intersection of biology and technology. At the most fundamental level, Illumina enable the customers to read and understand genetic variations. Illumina strive to make their solutions increasingly simple, more accessible, and always reliable. As a result, discoveries that were unimaginable even a few years ago are now becoming routine – and are making their way into patient treatment.
Illumina products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene variations associated with health, disease, and drug response. Every breakthrough opened up a new world, and showed how much further there is to go.
Illumina core technologies include:
- BeadArray Technology: A fundamentally different approach to high-density microarrays.
- Next-Generation Sequencing: Sequencing with unprecedented throughput, scalability, and speed. See what NGS can do for you.
- Sequencing by Synthesis (SBS) Technology: A highly economical, scalable NGS technology with unparalleled data density.
- Long-Read Sequencing Technology: An innovative sequencing technology for generating long reads that combines a new library prep method and bioinformatics tools.
For more details, please visit: illumina
